| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
Hospital for Children and Adolescents (E.K., L.D., S.A.), Laboratory (U.T.), and Departments of Clinical Chemistry (U.-H.S.) and Obstetrics and Gynecology (M.N., S.A.), Helsinki University Central Hospital, 00029 HUS, Helsinki, Finland; Endocrine Unit (P.J.W.), Southampton General Hospital, SO16 6YD Southampton, United Kingdom
Address all correspondence and requests for reprints to: Eero Kajantie, M.D., The Hospital for Children and Adolescents, Helsinki University Central Hospital, PL 280, 00029 HUS, Finland. E-mail: eero.kajantie{at}hus.fi.
Glucocorticoids rate among the most controversial topics in today’s perinatology and neonatology. Many sick preterm infants exhibit signs of adrenal insufficiency, the etiology, diagnostic criteria, and optimal treatment of which are under debate. Moreover, most of these infants are exposed to pharmacological glucocorticoid doses both in utero and after birth. In face of this, surprisingly little is known about the physiological glucocorticoid exposure before early preterm birth. This exposure is highly variable and mainly regulated by the placental enzyme 11ß-hydroxysteroid dehydrogenase-2 (11ß-HSD2), which converts excess cortisol (F) to inactive cortisone (E). Impaired activity of this enzyme is common in intrauterine growth restriction and preeclampsia, conditions frequently associated with early preterm birth. To identify clinical determinants associated with decreased placental 11ß-HSD2 function, we studied 107 small preterm infants [mean birth weight, 1067 g (range, 395-2453 g); gestational age, 28.2 wk (range, 22.4–32.0 wk)] by determining their placental 11ß-HSD2 activity rate (per milligram protein) and total activity (per placenta) as well as cord vein F and E concentrations. An E/(E+ F) ratio expresses the overall balance of the F/E shuttle. There were positive correlations between relative birth weight and placental 11ß-HSD2 activity rate (r = 0.30; P = 0.002) and total activity (r = 0.56; P < 0.0001) as well as E/(E+ F) ratio (r = 0.27; P = 0.01) and E concentration (r = 0.32; P = 0.003). Infants with increased umbilical artery resistance had lower total placental 11ß-HSD2 activity (P = 0.02), E/(E+ F) ratio (P = 0.04), and E concentration (P = 0.0002). Gestational age was inversely associated with placental 11ß-HSD2 activity rate (r = -0.25; P = 0.009). We conclude that, in small preterm infants, reduced placental 11ß-HSD2 function is associated with low relative birth weight and severe fetal distress. Whether these conditions are associated with early postnatal adrenal insufficiency or long-term cardiovascular risk remains an important issue for further study.
This work was supported by grants from Finska Läkaresällskapet, Helsinki University Central Hospital Research Fund, The Foundation for Pediatric Research, Paulo Foundation, Sigrid Jusélius Foundation, Sydäntutkimussäätiö, and Wiipurilaisen osakunnan stipendirahastot.
Abbreviations: E, cortisone; F, cortisol; HPA, hypothalamo-pituitary-adrenal; 11ß-HSD, 11ß-hydroxysteroid dehydrogenase; IUGR, intrauterine growth restriction.
This article has been cited by other articles:
 |
|
 |
|
  V Mericq, P Medina, E Kakarieka, L Marquez, M C Johnson, and G Iniguez Differences in expression and activity of 11{beta}-hydroxysteroid dehydrogenase type 1 and 2 in human placentas of term pregnancies according to birth weight and gender Eur. J. Endocrinol., September 1, 2009; 161(3): 419 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sharma, H. Guan, and K. Yang The p38 Mitogen-Activated Protein Kinase Regulates 11{beta}-Hydroxysteroid Dehydrogenase Type 2 (11{beta}-HSD2) Expression in Human Trophoblast Cells through Modulation of 11{beta}-HSD2 Messenger Ribonucleic Acid Stability Endocrinology, September 1, 2009; 150(9): 4278 - 4286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Stark, I. M. R. Wright, and V. L. Clifton Sex-specific alterations in placental 11{beta}-hydroxysteroid dehydrogenase 2 activity and early postnatal clinical course following antenatal betamethasone Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R510 - R514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Michael and A. T. Papageorghiou Potential significance of physiological and pharmacological glucocorticoids in early pregnancy Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kajantie, P. Hovi, K. Raikkonen, A.-K. Pesonen, K. Heinonen, A.-L. Jarvenpaa, J. G Eriksson, S. Strang-Karlsson, and S. Andersson Young Adults With Very Low Birth Weight: Leaving the Parental Home and Sexual Relationships--Helsinki Study of Very Low Birth Weight Adults Pediatrics, July 1, 2008; 122(1): e62 - e72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Gatford, J. A. Owens, S. Li, T. J. M. Moss, J. P. Newnham, J. R. G. Challis, and D. M. Sloboda Repeated betamethasone treatment of pregnant sheep programs persistent reductions in circulating IGF-I and IGF-binding proteins in progeny Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E170 - E178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Raikkonen, A.-K. Pesonen, K. Heinonen, E. Kajantie, P. Hovi, A.-L. Jarvenpaa, J. G. Eriksson, and S. Andersson Depression in Young Adults With Very Low Birth Weight: The Helsinki Study of Very Low-Birth-Weight Adults Arch Gen Psychiatry, March 1, 2008; 65(3): 290 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Atanasov, I. D. Ignatova, L. G. Nashev, B. Dick, P. Ferrari, F. J. Frey, and A. Odermatt Impaired Protein Stability of 11beta-Hydroxysteroid Dehydrogenase Type 2: A Novel Mechanism of Apparent Mineralocorticoid Excess J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1262 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kossintseva, S. Wong, E. Johnstone, L. Guilbert, D. M. Olson, and B. F. Mitchell Proinflammatory cytokines inhibit human placental 11{beta}-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP pathways Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E282 - E288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yang, L. Julan, F. Rubio, A. Sharma, and H. Guan Cadmium reduces 11{beta}-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E135 - E142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N van Montfoort, M J J Finken, S le Cessie, F W Dekker, and J M Wit Could cortisol explain the association between birth weight and cardiovascular disease in later life? A meta-analysis Eur. J. Endocrinol., December 1, 2005; 153(6): 811 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Lindsay and L. K. Nieman The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment Endocr. Rev., October 1, 2005; 26(6): 775 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kajantie, T. Raivio, O. a. Janne, P. Hovi, L. Dunkel, and S. Andersson Circulating Glucocorticoid Bioactivity in the Preterm Newborn after Antenatal Betamethasone Treatment J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3999 - 4003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kajantie, T. Hytinantti, P. Hovi, and S. Andersson Cord Plasma Adiponectin: A 20-Fold Rise between 24 Weeks Gestation and Term J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4031 - 4036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Klebanoff and K. C. Schoendorf Invited Commentary: What's So Bad about Curves Crossing Anyway? Am. J. Epidemiol., August 1, 2004; 160(3): 211 - 212. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
